Mortality due to KPC carbapenemase-producing Klebsiella pneumoniae infections: Systematic review and meta-analysis : Mortality due to KPC Klebsiella pneumoniae infections - 19/04/18
, Alberto Ruano-Ravina b, c, Raquel Barbosa-Lorenzo d, Jaime E. Paillier-Gonzalez e, Javier C. Saldaña-Campos f, Diego F. Salinas g, Elkin V. Lemos-Luengas hHighlights |
• | KPC-KP infection is highly lethal, with a mortality rate in the order of 40%. |
• | Mortality is observed to be variable, depending on the country and hospital ward in which patients are located. |
• | KPC-KP infection-related mortality has been rising in recent years. |
Abstract |
Introduction |
KPC carbapenemase-producing Klebsiella pneumoniae (KPC-KP) has become a major public health challenge. Accordingly, this study sought to use a systematic review of the scientific literature to ascertain the mortality of KPC-KP infection, and analyze such mortality by country, year of publication, hospital ward, and type of interpretation used to define carbapenem resistance.
Methodology |
A search without language restrictions was made of the MEDLINE, CENTRAL, EBSCO, LILACS and EMBASE databases from 1996 through June 2017, to locate all studies which had determined the existence of KPC-KP infection. We then performed a meta-analysis of all studies that reported KPC-KP infection-related mortality, and analyzed mortality by subgroup in accordance with standard methodology.
Results |
A total of 51 papers were included in the systematic review. From 2005 through 2017, data on KPC-KP infection were reported in 5124 patients, with an average of 465 patients per year. The most widely studied type of infection was bacteremia (28∙0%). The meta-analysis showed that overall mortality for the 37 studies was 41.0% (95%CI 37.0–44.0), with the highest mortality rates being observed in oncology patients, 56.0% (95%CI 38.1–73.0), and Brazil, 51.3% (95%CI 43.0–60.0).
Conclusion |
KPC-KP infection-related mortality is high, is manifested differently in some countries, and is highest among oncology patients.
Le texte complet de cet article est disponible en PDF.Keywords : Klebsiella pneumoniae, Carbapenemase, KPC, Bacterial resistance, Mortality
Plan
| This research is part of the work conducting to the PhD title of Jorge Andres Ramos Castañeda. |
Vol 76 - N° 5
P. 438-448 - mai 2018 Retour au numéro
Article précédent
- Meningococcal disease and control in China: Findings and updates from the Global Meningococcal Initiative (GMI)
- Junhong Li, Zhujun Shao, Gang Liu, Xilian Bai, Ray Borrow, Min Chen, Qinglan Guo, Yue Han, Yixing Li, Muhamed-Kheir Taha, Xihai Xu, Xin Xu, Huizhen Zheng
- Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women
- Monica Fabbrini, Fabio Rigat, Giovanna Tuscano, Emiliano Chiarot, Gilbert Donders, Roland Devlieger, Sara Filippini, Elisabetta Frigimelica, Pietro Forte, Frederick Wittke, Scott A. Halperin, Karen Slobod, Guido Grandi, Immaculada Margarit
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?